Chronic immunosupression in clinical transplantation is associated with morbidity and mortality. Induction of recipient unresponsiveness to donor antigens would decrease requirements for immunosuppression and reduce associated complications. A model of specific unresponsiveness has been developed in animals immunosuppressed with ALS and injected with donor bone marrow that prolongs the survival of skin allografts in mice and renal allografts in outbred dogs and rhesus monkeys. Objectives of the present application are (1) define the role of the histocompatibility complex in the induction of unresponsiveness utilizing either donor marrow or specific or nonspecific blood transfusions as antigen (2) characterize the cell(s) in marrow responsible for unresponsiveness (3) isolate and characterize the biological activity of suppressive factors in influencing unresponsiveness (4) undertake a clinical trial of induction of unresponsiveness in recipients of cadaveric or living-related transplants using ATG and donor bone marrow (5) develop assays for early detection of rejection in transplant patients. The genetic influence on unresponsiveness will be studied in congenic mice that differ at defined regions of the H-2 complex. Mice will be given ALS and either donor marrow or donor specific or nonspecific blood and immune reactivity will be studied by in vivo and in vitro assays. Cells contained in a marrow fraction shown to induce unresponsiveness will be characterized by examining surface markers and by their ability to respond in immune reactions. Somatic cell hybridization techniques will be used to obtain hybridoma cell lines of suppressor T cells derived from ALS treated mice given blood transfusions. Supernatants from cell cultures will be assayed for suppressive activity. Clinically, the induction of unresponsiveness will be performed in patients receiving either cadaver kidneys or living-related kidneys from one haplotype mismatched, high MLC positive donors. Patients will be followed serially for helper/suppressor T cell ratios and lymphocyte responses to polyclonal antigens and to donor specific and nonspecific antigens in an effort to identify the state of specific unreponsiveness. For the development of assays for detection of rejection, immunoglobulins shed from renal tubules and urinary CRP of transplant patients will be studied. A sensitive clinically applicable assay that will detect rejection before it is evident clinically should improve treatment of rejection and prevent loss of grafts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI014551-15
Application #
3125794
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1978-05-01
Project End
1993-04-30
Budget Start
1991-05-01
Budget End
1993-04-30
Support Year
15
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02215
Wan, Xiaoxiao; Zinselmeyer, Bernd H; Zakharov, Pavel N et al. (2018) Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides. Nature 560:107-111
Ferris, Stephen T; Zakharov, Pavel N; Wan, Xiaoxiao et al. (2017) The islet-resident macrophage is in an inflammatory state and senses microbial products in blood. J Exp Med 214:2369-2385
Umemura, A; Monaco, A P; Maki, T (2001) Essential role of MHC class II antigens in tolerance induction in allogeneic radiation chimera. Transplant Proc 33:112
Monaco, A P; Maki, T; Hale, D et al. (2001) The enigma of tolerance and chimerism: variable role of T cells and chimerism in induction of tolerance with bone marrow. Transplant Proc 33:3837-9
Umemura, A; Morita, H; Li, X C et al. (2001) Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation. J Immunol 167:3043-8
Umemura, A; Monaco, A P; Maki, T (2000) Donor MHC class II antigen is essential for induction of transplantation tolerance by bone marrow cells. J Immunol 164:4452-7
Hale, D A; Gottschalk, R; Umemura, A et al. (2000) Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation. Transplantation 69:1242-51
Umemura, A; Monaco, A P; Maki, T (2000) Donor T cells are not required for induction of allograft tolerance in mice treated with antilymphocyte serum, rapamycin, and donor bone marrow cells. Transplantation 70:1005-9
Hale, D A; Gottschalk, R; Maki, T et al. (1998) Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow. Transplantation 65:473-9
Hale, D A; Gottschalk, R; Fukuzaki, T et al. (1997) Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow. Transplantation 63:359-64

Showing the most recent 10 out of 24 publications